Environmental risk assessments for medicinal products containing, or consisting of, genetically modified organisms (GMOs)

Current effective version

PDF iconAdopted guideline

Reference numberEMEA/CHMP/473191/06 - Corr
Effective from01/07/2007
KeywordsGenetically modified organism (GMO), environmental risk assessment (ERA)
DescriptionThis document explains the application of the centralised procedure to marketing authorisation (MA) applications for medicinal products consisiting of or containing genetically modified organisms. It outlines both the procedural issues affecting applications for MA for these products and the information related to the environmental risk assessment which should be included in the applications.

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

In operation: 01/07/2007–present

Published: 01/12/2006

Published: 20/01/2005

Superseded document PDF iconAdopted guideline In operation: 01/01/1995–01/07/2007

Related content

How useful was this page?

Add your rating
1 rating